Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »


  • Kymab
  • Meditrina (B260), Babraham Research Campus
  • Cambridge ,
  • None

Kymab is a “platform to product” biopharmaceutical company engaged in the discovery and development of fully human monoclonal antibody drugs using its proprietary Kymouse™ transgenic antibody platform.

Related To This Company